相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mycophenolate mofetil in multiple sclerosis: a multicentre retrospective study on 344 patients
L. Michel et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial
Christian Confavreux et al.
LANCET NEUROLOGY (2014)
Diminished Th17 (not Th1) responses underlie multiple sclerosis disease abrogation after hematopoietic stem cell transplantation
Peter J. Darlington et al.
ANNALS OF NEUROLOGY (2013)
Teriflunomide: A Review of Its Use in Relapsing Multiple Sclerosis
Karly P. Garnock-Jones
CNS DRUGS (2013)
Drugs in Development for Relapsing Multiple Sclerosis
Rehiana Ali et al.
DRUGS (2013)
The benefits and risks of alemtuzumab in multiple sclerosis
Daniel Ontaneda et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2013)
The astrocyte in multiple sclerosis revisited
Celia F. Brosnan et al.
GLIA (2013)
The effects of teriflunomide on lymphocyte subpopulations in human peripheral blood mononuclear cells in vitro
Li Li et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Magnetic resonance imaging outcomes from a phase III trial of teriflunomide
Jerry S. Wolinsky et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Dendritic cells in multiple sclerosis: key players in the immunopathogenesis, key players for new cellular immunotherapies?
A. H. Nuyts et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
Ashley H. Beecham et al.
NATURE GENETICS (2013)
MULTIPLE SCLEROSIS: Reprogramming the immune repertoire with alemtuzumab in MS
Heinz Wiendl et al.
NATURE REVIEWS NEUROLOGY (2013)
Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis
Amit Bar-Or et al.
NEUROLOGY (2013)
Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17-and Activated B-Cells and Correlates with Progression
Jeppe Romme Christensen et al.
PLOS ONE (2013)
Neurons as targets for T cells in the nervous system
Roland S. Liblau et al.
TRENDS IN NEUROSCIENCES (2013)
IL-10-producing regulatory B cells (B10 cells) in autoimmune disease
Ioannis Kalampokis et al.
ARTHRITIS RESEARCH & THERAPY (2013)
The role of natural killer cells in multiple sclerosis and their therapeutic implications
Coralie Chanvillard et al.
FRONTIERS IN IMMUNOLOGY (2013)
Effects of Prophylactic and Therapeutic Teriflunomide in Transcranial Magnetic Stimulation-Induced Motor-Evoked Potentials in the Dark Agouti Rat Model of Experimental Autoimmune Encephalomyelitis
Deborah Iglesias-Bregna et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Fingolimod Impedes Schwann Cell-Mediated Myelination Implications for the Treatment of Immune Neuropathies?
Angelika Koehne et al.
ARCHIVES OF NEUROLOGY (2012)
Pregnancy outcome in women exposed to leflunomide before or during pregnancy
M. Cassina et al.
ARTHRITIS AND RHEUMATISM (2012)
Mitoxantrone repression of astrocyte activation: Relevance to multiple sclerosis
Samuel A. Burns et al.
BRAIN RESEARCH (2012)
Regional Neural Activation Defines a Gateway for Autoreactive T Cells to Cross the Blood-Brain Barrier
Yasunobu Arima et al.
CELL (2012)
Anti-CD25 (daclizumab) monoclonal antibody therapy in relapsing-remitting multiple sclerosis
Roland Martin
CLINICAL IMMUNOLOGY (2012)
Immune mechanisms of new therapeutic strategies in MS - Teriflunomide
Malte C. Claussen et al.
CLINICAL IMMUNOLOGY (2012)
Treatment of multiple sclerosis with Anti-CD20 antibodies
Barbara Barun et al.
CLINICAL IMMUNOLOGY (2012)
An aggregation sensing reporter identifies leflunomide and teriflunomide as polyglutamine aggregate inhibitors
Rodrigo A. Fuentealba et al.
HUMAN MOLECULAR GENETICS (2012)
Dimethyl Fumarate Inhibits Dendritic Cell Maturation via Nuclear Factor κB (NF-κB) and Extracellular Signal-regulated Kinase 1 and 2 (ERK1/2) and Mitogen Stress-activated Kinase 1 (MSK1) Signaling
Haiyan Peng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
B cell exchange across the blood-brain barrier in multiple sclerosis
H. -Christian von Buedingen et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells
Tom A. Barr et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Altered frequency of T regulatory cells is associated with disability status in relapsing-remitting multiple sclerosis patients
Lasse Bjerg et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
Antibody to α4 integrin suppresses natural killer cells infiltration in central nervous system in experimental autoimmune encephalomyelitis
Yan Gan et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
Laquinimod modulates B cells and their regulatory effects on T cells in Multiple Sclerosis
Elias Toubi et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
Oral treatment with laquinimod augments regulatory T-cells and brain-derived neurotrophic factor expression and reduces injury in the CNS of mice with experimental autoimmune encephalomyelitis
Rina Aharoni et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
Long-term follow-up of a phase 2 study of oral teriflunomide in relapsing multiple sclerosis: safety and efficacy results up to 8.5 years
Christian Confavreux et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
B cells and antibodies in multiple sclerosis pathogenesis and therapy
Markus Krumbholz et al.
NATURE REVIEWS NEUROLOGY (2012)
Laquinimod, a Quinoline-3-Carboxamide, Induces Type II Myeloid Cells That Modulate Central Nervous System Autoimmunity
Ulf Schulze-Topphoff et al.
PLOS ONE (2012)
Long-Term Decrease in VLA-4 Expression and Functional Impairment of Dendritic Cells during Natalizumab Therapy in Patients with Multiple Sclerosis
Clara de Andres et al.
PLOS ONE (2012)
Natalizumab Exerts Direct Signaling Capacity and Supports a Pro-Inflammatory Phenotype in Some Patients with Multiple Sclerosis
Thomas F. Benkert et al.
PLOS ONE (2012)
Effect of Natalizumab on Circulating CD4+ T-Cells in Multiple Sclerosis
Lars Bornsen et al.
PLOS ONE (2012)
Fumarates Promote Cytoprotection of Central Nervous System Cells against Oxidative Stress via the Nuclear Factor (Erythroid-Derived 2)-Like 2 Pathway
Robert H. Scannevin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Pathophysiology of multiple sclerosis and the place of teriflunomide
R. Gold et al.
ACTA NEUROLOGICA SCANDINAVICA (2011)
Increased Sensitivity to Apoptosis Induced by Methotrexate Is Mediated by JNK
Charles F. Spurlock et al.
ARTHRITIS AND RHEUMATISM (2011)
Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells
Yohei Iwata et al.
BLOOD (2011)
Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis
Laura Lovato et al.
BRAIN (2011)
B cells in multiple sclerosis: connecting the dots
H-Christian von Buedingen et al.
CURRENT OPINION IN IMMUNOLOGY (2011)
A case for regulatory B cells in controlling the severity of autoimmune-mediated inflammation in experimental autoimmune encephalomyelitis and multiple sclerosis
Avijit Ray et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
Ludwig Kappos et al.
LANCET (2011)
A role for interleukin-2 trans-presentation in dendritic cell-mediated T cell activation in humans, as revealed by daclizumab therapy
Simone C. Wuest et al.
NATURE MEDICINE (2011)
Inflammatory Cortical Demyelination in Early Multiple Sclerosis
Claudia F. Lucchinetti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
Paul O'Connor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis
Ranjan Dutta et al.
PROGRESS IN NEUROBIOLOGY (2011)
Efficacy, safety, and cost-effectiveness of glatiramer acetate in the treatment of relapsing–remitting multiple sclerosis
Aaron Boster et al.
Therapeutic Advances in Neurological Disorders (2011)
Fingolimod (FTY720) Enhances Remyelination Following Demyelination of Organotypic Cerebellar Slices
Veronique E. Miron et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Abnormal B-Cell Cytokine Responses A Trigger of T-Cell Mediated Disease in MS?
Amit Bar-Or et al.
ANNALS OF NEUROLOGY (2010)
Birth Outcomes in Women Who Have Taken Leflunomide During Pregnancy
Christina D. Chambers et al.
ARTHRITIS AND RHEUMATISM (2010)
Therapy of MS
Reza Vosoughi et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2010)
Metabolism in T cell activation and differentiation
Erika L. Pearce
CURRENT OPINION IN IMMUNOLOGY (2010)
An IL-2 Paradox: Blocking CD25 on T Cells Induces IL-2-Driven Activation of CD56bright NK Cells
Jayne F. Martin et al.
JOURNAL OF IMMUNOLOGY (2010)
Neuropathogenesis of Theiler's Murine Encephalomyelitis Virus Infection, An Animal Model for Multiple Sclerosis
Ikuo Tsunoda et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2010)
Natalizumab treatment reduces endothelial activity in MS patients
Alban Millonig et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Laquinimod interferes with migratory capacity of T cells and reduces IL-17 levels, inflammatory demyelination and acute axonal damage in mice with experimental autoimmune encephalomyelitis
Christiane Wegner et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Effects of Fumaric Acids on Cuprizone Induced Central Nervous System De- and Remyelination in the Mouse
Darius Moharregh-Khiabani et al.
PLOS ONE (2010)
Pathogenic CD8+ T Cells in Multiple Sclerosis
Manuel A. Friese et al.
ANNALS OF NEUROLOGY (2009)
The relation between inflammation and neurodegeneration in multiple sclerosis brains
Josa M. Frischer et al.
BRAIN (2009)
Multiple sclerosis: Human model for EAE?
Reinhard Hohfeld
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
CD8+ T cells and neuronal damage: direct and collateral mechanisms of cytotoxicity and impaired electrical excitability
Nico Melzer et al.
FASEB JOURNAL (2009)
Teriflunomide reduces behavioral, electrophysiological, and histopathological deficits in the Dark Agouti rat model of experimental autoimmune encephalomyelitis
Jean E. Merrill et al.
JOURNAL OF NEUROLOGY (2009)
C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE
Andrea Reboldi et al.
NATURE IMMUNOLOGY (2009)
Promoting oligodendrogenesis and myelin repair using the multiple sclerosis medication glatiramer acetate
Viktor Skihar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
β1 integrins differentially control extravasation of inflammatory cell subsets into the CNS during autoimmunity
Martina Bauer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Chemotherapy-induced Alopecia
Ralph M. Trueeb
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY (2009)
Mycophenolate mofetil: effects on cellular immune subsets, infectious complications, and antimicrobial activity
M. L. Ritter et al.
TRANSPLANT INFECTIOUS DISEASE (2009)
Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis
John S. Tzartos et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Helminth infections associated with multiple sclerosis induce regulatory B cells
Jorge Correale et al.
ANNALS OF NEUROLOGY (2008)
Multiple sclerosis: An immune or neurodegenerative disorder?
Bruce D. Trapp et al.
ANNUAL REVIEW OF NEUROSCIENCE (2008)
The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation
Alla L. Zozulya et al.
HUMAN IMMUNOLOGY (2008)
The role of regulatory T cells in multiple sclerosis
Alla L. Zozulya et al.
NATURE CLINICAL PRACTICE NEUROLOGY (2008)
The immunomodulatory drug Leflunomide inhibits cell cycle progression of B-CLL cells
I. Ringshausen et al.
LEUKEMIA (2008)
The immunomodulator FTY720 has a direct cytoprotective effect in oligodendrocyte progenitors
Rochelle P. Coelho et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation
Hania Kebir et al.
NATURE MEDICINE (2007)
An antigen-specific pathway for CD8 T cells across the blood-brain barrier
Ian Galea et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptors
Florian Mullershausen et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis
Martin Duddy et al.
JOURNAL OF IMMUNOLOGY (2007)
APC-derived cytokines and T cell polarization in autoimmune inflammation
Ilona Gutcher et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Azathioprine. Safety profile in multiple sclerosis patients
L. La Mantia et al.
NEUROLOGICAL SCIENCES (2007)
Pancytopenia related to low-dose methotrexate: study of five cases and review of the literature
K. Serraj et al.
REVUE DE MEDECINE INTERNE (2007)
Multiple sclerosis: a complicated picture of autoimmunity
Henry F. McFarland et al.
NATURE IMMUNOLOGY (2007)
The neurobiology of multiple sclerosis: Genes, inflammation, and neurodegeneration
Stephen L. Hauser et al.
NEURON (2006)
A pathogenic role for CD8+ T cells in a spontaneous model of demyelinating disease
Marcel Brisebois et al.
JOURNAL OF IMMUNOLOGY (2006)
Fumaric acid esters are effective in chronic experimental autoimmune encephalomyelitis and suppress macrophage infiltration
S. Schilling et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses
PW O'Connor et al.
NEUROLOGY (2006)
Understanding the IL-23-IL-17 immune pathway
BS McKenzie et al.
TRENDS IN IMMUNOLOGY (2006)
Disruption of the interaction of T cells with antigen-presenting cells by the active leflunomide metabolite teriflunomide -: Involvement of impaired integrin activation and immunologic synapse formation
M Zeyda et al.
ARTHRITIS AND RHEUMATISM (2005)
Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide
MEC Lutsiak et al.
BLOOD (2005)
Defining antigen-dependent stages of T cell migration from the blood to the central nervous system parenchyma
AS Archambault et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
The anti-inflammatory action of methotrexate is not mediated by lymphocyte apoptosis, but by the suppression of activation and adhesion molecules
A Johnston et al.
CLINICAL IMMUNOLOGY (2005)
Mitoxantrone induces cell death in peripheral blood leucocytes of multiple sclerosis patients
A Chan et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2005)
Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis
B Serafini et al.
BRAIN PATHOLOGY (2004)
Expansion and functional relevance of high-avidity myelin-specific CD4+ T cells in multiple sclerosis
B Bielekova et al.
JOURNAL OF IMMUNOLOGY (2004)
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
M Matloubian et al.
NATURE (2004)
Modulation of effector cell functions in experimental autoimmune encephalomyelitis by leflunomide - mechanisms independent of pyrimidine depletion
T Korn et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: From pipe dreams to (therapeutic) pipelines
R Hohlfeid et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay
MP Crawford et al.
BLOOD (2004)
Dihydroorotate dehydrogenase mRNA and protein expression analysis in normal and drug-resistant cells
M Löffler et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2004)
Interferon-β-1b decreased matrix metalloproteinase-9 serum levels in primary progressive multiple sclerosis
M Yushchenko et al.
JOURNAL OF NEUROLOGY (2003)
Three or more routes for leukocyte migration into the central nervous system
RM Ransohoff et al.
NATURE REVIEWS IMMUNOLOGY (2003)
Differential control of cell cycle, proliferation, and survival of primary T lymphocytes by purine and pyrimidine nucleotides
L Quéméneur et al.
JOURNAL OF IMMUNOLOGY (2003)
Glatiramer acetate (copolymer-1, Copaxone) promotes Th2 cell development and increased IL-10 production through modulation of dendritic cells
PL Vieira et al.
JOURNAL OF IMMUNOLOGY (2003)
Sphingosine-1-phosphate receptor agonism impairs the efficiency of the local immune response by altering trafficking of naive and antigen-activated CD4+ T cells
JH Xie et al.
JOURNAL OF IMMUNOLOGY (2003)
The 'Immunological-Synapse' at its APC side in relapsing and secondary-progressive multiple sclerosis: modulation by interferon-beta
S Shapiro et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
Dimethylfumarate is a potent inducer of apoptosis in human T cells
F Treumer et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Restriction of de novo pyrimidine biosynthesis inhibits Th1 cell activation and promotes Th2 cell differentiation
P Dimitrova et al.
JOURNAL OF IMMUNOLOGY (2002)
Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists
S Mandala et al.
SCIENCE (2002)
Suppression of experimental autoimmune neuritis by ABR-215062 is associated with altered Th1/Th2 balance and inhibited migration of inflammatory cells into the peripheral nerve tissue
LP Zou et al.
NEUROPHARMACOLOGY (2002)
Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects
HL Weiner et al.
MULTIPLE SCLEROSIS JOURNAL (2002)
Specific Th2 cells accumulate in the central nervous system of mice protected against experimental autoimmune encephalomyelitis by copolymer 1
R Aharoni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Multiple sclerosis is associated with an imbalance between tumour necrosis factor-alpha (TNF-α)- and IL-10-secreting blood cells that is corrected by interferon-beta (IFN-β) treatment
V Özenci et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2000)
Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients
M Colombo et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
